In a significant stride for chronic disease management, FDA granted approvals for Roche’s lupus nephritis treatment and Novo Nordisk’s cardiovascular-risk-reducing oral semaglutide for adults with ...

Hims & Hers is emerging as a disruptive force in the obesity treatment market, challenging established GLP-1 drug makers.

WeightWatchers said on Monday it will partner with Amazon to deliver medications including injectable GLP-1 obesity ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

In what some news reports dubbed " an awkward moment ," CMS Administrator Mehmet Oz, MD, stepped up to the podium in the Oval Office last week to correct President Donald Trump on the status of GLP-1 ...

Pfizer ( PFE) is number one and the leader in my list of "top 3 Big Pharma stocks." Over the last three quarters I have seen ...

Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...

President Trump wants to lower GLP-1 prices; Novo Nordisk hires new corporate affairs lead; FDA announces priority drug review candidates.

WW International shares rise nearly 6% after announcing a partnership with Amazon Pharmacy to deliver GLP-1 weight-loss drugs directly to customers.

Canadian company Vimy Pharma aims to produce a generic version of blockbuster drug Ozempic to provide an affordable option ...

Eli Lilly's Mounjaro clocked in ₹80 crore in September, second only to India’s leading brand of the month, GSK’s Augmentin, ...

WeightWatchers Clinic can now get weight loss medications though Amazon Pharmacy (NASDAQ:AMZN), capitalizing on the proliferation of GLP-1s with Amazon’s fast and free delivery for Prime members.